Search results for " cutaneous"

showing 10 items of 172 documents

Suppression of extinction with TMS in humans: from healthy controls to patients.

2006

We review a series of studies exemplifying some applications of single-pulse and paired-transcranial magnetic stimulation (TMS) in the study of spatial attention and of its deficits. We will focus primarily on sensory extinction, the failure to consciously perceive a contralesional sensory stimulus only during bilateral stimulation of homologous surfaces. TMS studies in healthy controls show that it is possible either to interfere or modulate the excitability of the parietal cortex during sensory (i.e. tactile and visual) attentional tasks, thus reproducing a condition of virtual extinction. TMS studies in patients with unilateral (mainly right) brain damage show that the modulation of the …

Visual perceptionmedicine.medical_treatmentINHIBITIONPosterior parietal cortexNeurosciences. Biological psychiatry. NeuropsychiatrySensory systemStimulationTACTILE SPACEBrain damageFunctional LateralityExtinction PsychologicalPARIETAL CORTEXParietal LobemedicineHumansCUTANEOUS STIMULIMOTOR CORTEXTRANSCRANIAL MAGNETIC STIMULATION; CUTANEOUS STIMULI; PULSE STIMULATION; PARIETAL CORTEX; TACTILE SPACE; MOTOR CORTEX; HUMAN BRAIN; NEGLECT; INHIBITION; PERCEPTIONPERCEPTIONSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaParietal lobeExtinctionGeneral Medicinemedicine.diseaseHUMAN BRAINTranscranial Magnetic StimulationSensation Disorders; Extinction Psychological; Humans; Space Perception; Transcranial Magnetic Stimulation; Parietal Lobe; Visual Perception; Touch; Functional LateralityTranscranial magnetic stimulationNeuropsychology and Physiological PsychologyNeurologyNEGLECTTouchExtinction (neurology)Space PerceptionPULSE STIMULATIONSensation DisordersVisual PerceptionPsychologicalSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptomPsychologyNeuroscienceRC321-571Research ArticleBehavioural neurology
researchProduct

Anatomy of nerves of the lower extremities in the context of the treatment for varicose veins

2019

Injury of nerves of the lower extremity is the most prevalent complication associated with invasive treatment of varicose veins. These adverse events are particularly frequent after traditional surgical stripping and thermal ablative procedures. The most frequently injured nerves comprise the saphenous nerve, the sural nerve, and the anterior cutaneous branch of the femoral nerve. The high rate of injury to these nerves is primarily related to their close anatomical relationship with major trunks of the superficial venous system. The great saphenous vein is accompanied by two groups of sensory nerves. In its proximal part it runs along the anterior cutaneous branch of the femoral nerve. In …

anatomybusiness.industrySural nerveContext (language use)anterior cutaneous branch of femoral nerveAnatomyNerve injurysurgerySaphenous nervesaphenous nervesural nerveVaricose veinsMedicinenerve injurymedicine.symptomvaricose veinsbusinessPhlebological Review
researchProduct

Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy.

2007

Studies in murine experimental Leishmania major infection have helped to understand the requirements for efficient development of T helper (Th)1/cytotoxic T (Tc)1-mediated protection against the parasite. As such they have revealed that Fc gamma receptor (Fc gamma R)I and Fc gamma RIII-mediated uptake of L. major amastigotes by dendritic cells (DC) is an important prerequisite for Th1 development. In addition, DC-derived cytokines contribute to adequate T-cell education. DC-based vaccines may thus provide an important tool for both the development of a prophylactic vaccine against leishmaniasis and - together with leishmanicidal drugs - for eliciting immune-deviating functions towards prote…

biologyLeishmaniasis CutaneousLeishmaniasisDermatologyDendritic cellmedicine.diseaseLeishmaniabiology.organism_classificationBiochemistryVirologyImmunityImmunologymedicineCytotoxic T cellAnimalsHumansLeishmania majorAntigen-presenting cellAmastigoteMolecular BiologyLeishmania majorSkinExperimental dermatology
researchProduct

Iontophoresis: electrorepulsion and electroosmosis.

2000

Over the last 10-15 years, the electrical enhancement of drug delivery across the skin has undergone intense investigation. During this period, considerable amounts of experimental data have been generated, and the successful enhancement of a diverse array of molecules has been achieved. Indeed, the commercial exploitation of the method can be envisaged within the next few years. Despite this progress, however, the mechanistic understanding of iontophoresis remains a challenging scientific question that is yet to be fully resolved. The routes of permeation under the influence of an applied electrical potential, and the molecular interactions of the transporting drug with these pathways, hav…

ddc:615Molecular interactionsOsmosisIontophoresisChemistryPharmaceutical ScienceNanotechnologyIontophoresisAdministration CutaneousDrug Delivery SystemsPharmaceutical technologyElectricitySkin Physiological PhenomenaDrug deliveryDrug Delivery Systems/methodsJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Topical anti-inflammatory potential of quercetin in lipid-based nanosystems: In vivo and in vitro evaluation

2013

Purpose: To develop quercetin-loaded phospholipid vesicles, namely liposomes and PEVs (Penetration Enhancer-containing Vesicles), and to investigate their efficacy on TPA-induced skin inflammation. Methods: Vesicles were made from a mixture of phospholipids, quercetin and polyethylene glycol 400 (PEG), specifically added to increase drug solubility and penetration through the skin. Vesicle morphology and self-assembly were probed by Cryo-Transmission Electron Microscopy and Small/Wide Angle X-ray Scattering, as well as the main physico-chemical features by Light Scattering. The anti-inflammatory efficacy of quercetin nanovesicles was assessed in vivo on TPA-treated mice dorsal skin by the d…

dermal fibroblastsmiceSkin AbsorptionAnti-Inflammatory AgentsDrug Evaluation PreclinicalPharmaceutical ScienceInflammationPharmacologyAdministration Cutaneousquercetinchemistry.chemical_compoundX-Ray DiffractionIn vivoskin inflammationmedicineAnimalsheterocyclic compoundsPharmacology (medical)PharmacologyDrug CarriersLiposomevesiclesintegumentary systemVesiclefungiOrganic Chemistry3T3 CellsPenetration (firestop)In vitrochemistryLiposomesNanoparticlesMolecular MedicineFemaleTopical anti-inflammatorymedicine.symptomQuercetinBiotechnology
researchProduct

Current Progress in Particle-Based Systems for Transdermal Vaccine Delivery

2020

Transcutaneous immunization (TCI) via needle-free and non-invasive drug delivery systems is a promising approach for overcoming the current limitations of conventional parenteral vaccination methods. The targeted access to professional antigen-presenting cell (APC) populations within the skin, such as Langerhans cells (LCs), various dermal dendritic cells (dDCs), macrophages, and others makes the skin an ideal vaccination site to specifically shape immune responses as required. The stratum corneum (SC) of the skin is the main penetration barrier that needs to be overcome by the vaccine components in a coordinated way to achieve optimal access to dermal APC populations that induce priming of…

lcsh:Immunologic diseases. AllergyOvalbuminMini ReviewT-Lymphocytesparticulate systemsImmunologyAntigen-Presenting CellsAdministration CutaneousSonicationDrug Delivery SystemsImmune systemtranscutaneous immunizationAdjuvants ImmunologicAntigenvaccine particlesStratum corneumHumansImmunology and AllergyMedicineVaccines Virus-Like ParticleParticle SizeTransdermalIontophoresisintegumentary systembusiness.industryElectroporationVaccinationDermisPeptide Fragmentsneedle-free vaccinationVaccinationElectroporationmedicine.anatomical_structureLangerhans CellsLiposomesImmunologyDrug deliverydrug deliveryInjections JetnanoparticlesLymph NodesPharmaceutical Vehiclesbusinesslcsh:RC581-607Frontiers in Immunology
researchProduct

Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients.

2007

The threshold of toxicological concern (TTC) has been used for the safety assessment of packaging migrants and flavouring agents that occur in food. The approach compares the estimated oral intake with a TTC value derived from chronic oral toxicity data for structurally-related compounds. Application of the TTC approach to cosmetic ingredients and impurities requires consideration of whether route-dependent differences in first-pass metabolism could affect the applicability of TTC values derived from oral data to the topical route. The physicochemical characteristics of the chemical and the pattern of cosmetic use would affect the long-term average internal dose that is compared with the re…

media_common.quotation_subjectAdministration OralCosmeticsToxicologyAdministration CutaneousCosmeticsDecision Support TechniquesToxicologyToxicity TestsHumansPredicted no-effect concentrationcardiovascular diseasesTopical routeOral toxicitymedia_commonNo-Observed-Adverse-Effect LevelChemistrySkin sensitizationDecision TreesGeneral MedicineFragrance ingredientDermal sensitizationRisk analysis (engineering)Internal doseSafetyFood ScienceFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association
researchProduct

Anti-inflammatory activity of two cucurbitacins isolated from Cayaponia tayuya roots.

2004

Fractionation of an anti-inflammatory extract from Cayaponia tayuya roots yielded two active compounds, identified as 23,24-dihydrocucurbitacin B (1) and cucurbitacin R (2). Both were evaluated for their anti-inflammatory activity on several experimental models of pain and inflammation. In addition, their cytotoxicity and effects on leukotriene B 4 (LTB 4 ) formation were evaluated in rat polymorphonuclear leukocytes. Both compounds showed activity in the following models: carrageenan-induced mouse paw oedema (1, 4 mg/kg p.o., 46% inhibition at 3 h), phospholipase A 2 -induced mouse paw oedema (2, 3 mg/kg i.p., 61% inhibition at 60 min), serotonin-induced mouse paw oedema (1 and 2, 0.5 mg/k…

medicine.drug_classLeukotriene B4Pharmaceutical ScienceAdministration OralPainPharmacologyAdministration CutaneousCarrageenanLeukotriene B4Plant RootsAnti-inflammatoryPhospholipases AAnalytical Chemistrychemistry.chemical_compoundMicePhospholipase A2Drug DiscoverymedicineLeukocytesAnimalsEdemaRats WistarPharmacologyPhospholipase AbiologyDose-Response Relationship DrugPlant ExtractsAntiglucocorticoidOrganic ChemistryAnti-Inflammatory Agents Non-SteroidalCucurbitacinsbiology.organism_classificationCayaponia tayuyaTriterpenesCarrageenanRatsCucurbitaceaePhospholipases A2Complementary and alternative medicinechemistryBiochemistryEicosanoidbiology.proteinMolecular MedicineTetradecanoylphorbol AcetateFemalePhytotherapyPlanta medica
researchProduct

Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol.

2012

ABSTRACT Objective To describe the effect of the intermittent administration of vaginal progesterone and a low-dose estradiol patch on endometrial stability, as assessed by the rate of amenorrhea and endometrial stimulation. Methods This was an open study in which 64 moderately symptomatic, postmenopausal women were treated in the outpatient clinic of our University Hospital for different intervals up to 1 year. The treatment consisted of a combination of patches delivering 25 µg/day estradiol and intravaginal pills containing 100 mg of micronized progesterone. Patches and pills were administered concomitantly in a twice-a-week protocol. The endometrial response was assessed by endovaginal …

medicine.medical_specialtyBiopsyEndometriumAdministration CutaneousEndometriumBiopsymedicineOutpatient clinicHumansProgesteroneTransdermalUltrasonographyGynecologymedicine.diagnostic_testEstradiolUterine Hemorrhagebusiness.industryEstrogen Replacement TherapyObstetrics and GynecologyGeneral MedicineMiddle AgedUniversity hospitalPostmenopauseAdministration Intravaginalmedicine.anatomical_structurePillAmenorrheaFemaleUterine Hemorrhagemedicine.symptomAtrophybusinessClimacteric : the journal of the International Menopause Society
researchProduct

Safety of Topical Non-steroidal Anti-Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis

2019

Objective We aimed to assess the safety of topical non-steroidal anti-inflammatory drugs (NSAIDs) in the management of osteoarthritis (OA) in a systematic review and meta-analysis of randomized, placebo-controlled trials. Methods A comprehensive literature search was undertaken in the MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL), and Scopus electronic databases. Randomized, double-blind, placebo-controlled, parallel-group trials that assessed adverse events (AEs) with topical NSAIDs in patients with OA were eligible for inclusion. Authors and/or study sponsors were contacted to obtain the full report of AEs. The primary outcomes were overall severe and serious AEs, as w…

medicine.medical_specialtyDICLOFENAC SODIUM GELDiclofenacDrug-Related Side Effects and Adverse ReactionsMedDRAVEHICLE TDT 064MEDLINEOsteoarthritisKNEE OSTEOARTHRITISAdministration CutaneousPlaceboLONG-TERM USE03 medical and health sciencesDOUBLE-BLIND0302 clinical medicinePharmacotherapyInternal medicineOsteoarthritisHumansMedicinePharmacology (medical)030212 general & internal medicineAdverse effectRandomized Controlled Trials as Topicbusiness.industryAnti-Inflammatory Agents Non-SteroidalTRANSFERSOME GELOdds ratiomedicine.diseaseEFFICACYRANDOMIZED CLINICAL-TRIALORAL CELECOXIBTreatment OutcomeMeta-analysisSystematic ReviewGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryTASK-FORCE
researchProduct